跳至主要内容
临床试验/NCT06077357
NCT06077357已完成不适用

Evaluation of Frailty, Hand Grip Strength, Physically Activity, Kinesiophobia and Fatigue in Chronic Obstructive Pulmonary Disease and Asymptomatic Geriatric Individual

Kırıkkale University2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年1月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
2
主要终点
The Fatigue Severity Scale

研究概览

简要总结

The literature does not provide sufficient information on the evaluation of frailty, handgrip strength, physical activity, kinesiophobia, and fatigue in elderly individuals with Chronic Obstructive Pulmonary Disease and asymptomatic elderly individuals. Additionally, there is a gap in the literature regarding the impact of COPD on these parameters in geriatric individuals diagnosed with Chronic Obstructive Pulmonary Disease . To fill this gap in the literature and to establish treatment approaches based on the results of parameters studied in elderly individuals with Chronic Obstructive Pulmonary Disease in future studies.

详细描述

Chronic Obstructive Pulmonary Disease (COPD) is a prevalent condition among the elderly population, considered a leading cause of morbidity and mortality. It is characterized by chronic inflammatory responses associated with harmful particles or gases in the airways and lungs, resulting in persistent airflow limitation that is both preventable and treatable . While cough and sputum are reported as clinical symptoms in COPD cases, the most prominent clinical symptom is dyspnea. Age-related physiological changes and frailty lead to a decrease in levels of physical activity. The resulting deconditioning from reduced physical activity causes a decline in ventilation quality, creating a vicious cycle that progressively exacerbates dyspnea. This study involves the comparison of individuals diagnosed with COPD with asymptomatic geriatric individuals. Its aim is to examine the effects of COPD on frailty, handgrip strength, physical activity, kinesiophobia, and fatigue.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inclusion Criteria for COPD Patients:
  • Having received a diagnosis of COPD
  • Being 65 years of age or older
  • Volunteering to participate in the study
  • Not having any mental or communication issues that would hinder the completion of the questionnaires to be used in the research
  • Inclusion Criteria for Asymptomatic Individuals:
  • Not having received a diagnosis of COPD
  • Being 65 years of age or older
  • Volunteering to participate in the study
  • Not having any mental or communication issues that would hinder the completion of the questionnaires to be used in the research

排除标准

  • Exclusion Criteria for COPD and Asymptomatic Individuals:
  • Having a diagnosis of both physical and mental illnesses
  • Being diagnosed with unstable COPD
  • Having conditions such as unstable angina, prior heart attack, uncontrolled hypertension, cancer, and neurological disorders accompanied by functional limitations
  • Currently being addicted to alcohol or substances
  • Having severe visual and hearing impairments
  • Having undergone major surgery in the past few months
  • Having a history of recurring significant clinical infections.

结局指标

主要结局

The Fatigue Severity Scale

时间窗: 4 months

The Fatigue Severity Scale evaluates the severity of fatigue through 9 questions, with scores ranging from 9 to 63 on the scale. Each question is scored on a 1 (completely disagree) to 7 (completely agree) Likert scale. A higher score indicates increased severity of fatigue.A higher score is worse.

次要结局

  • Hand Grip Strength Measurement(4 months)
  • The Tampa Scale of Kinesiophobia(4 months)
  • The Mini Mental Test (MMT)(4 months)
  • PRISMA-7 Fragility Test(4 months)
  • The Physical Activity Scale for the Elderly (PASE)(4 months)

研究者

发起方
Kırıkkale University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Meral SERTEL

ASSOCIATE PROFESSOR DOCTOR

Kırıkkale University

研究点 (2)

Loading locations...

相似试验

Evaluation in Individuals with COPD and Asymptomatic... | 临床试验